Literature DB >> 16301611

Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner.

M Paula Longhi1, Baalasubramanian Sivasankar, Nader Omidvar, B Paul Morgan, Awen Gallimore.   

Abstract

CD59 blocks formation of the membrane attack complex of complement by inhibiting binding of C9 to the C5b-8 complex. To investigate a role for CD59 in promoting T cell responses, we compared T cell activation in CD59a-deficient (Cd59a-/-) and wild-type (WT) mice after in vitro stimulation and after infection with rVV. Virus-specific CD4+ T cell responses were significantly enhanced in Cd59a-/- mice compared with WT mice. Similarly, Cd59a-/- T cells responded more vigorously to in vitro stimulation with CD3-specific Abs compared with WT mice. This effect of CD59a on T cell proliferation was found to be complement-independent. Collectively, these results demonstrate that CD59a down-modulates CD4+ T cell activity in vitro and in vivo, thereby revealing another link between complement regulators and T cell activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301611      PMCID: PMC1455165          DOI: 10.4049/jimmunol.175.11.7098

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.

Authors:  Imre Farkas; Lajos Baranyi; Yasushige Ishikawa; Noriko Okada; Csaba Bohata; Denes Budai; Atsuo Fukuda; Masaki Imai; Hidechika Okada
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

2.  Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria.

Authors:  D S Holt; M Botto; A E Bygrave; S M Hanna; M J Walport; B P Morgan
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

3.  Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.

Authors:  Claire L Harris; S Melanie Hanna; Masashi Mizuno; Dewi S Holt; Kevin J Marchbank; B Paul Morgan
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

4.  A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

Authors:  Julie C Fitzgerald; Guang-Ping Gao; Arturo Reyes-Sandoval; George N Pavlakis; Zhi Q Xiang; Anthony P Wlazlo; Wynetta Giles-Davis; James M Wilson; Hildegund C J Ertl
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

5.  IL-12 is not required for induction of type 1 cytokine responses in viral infections.

Authors:  A Oxenius; U Karrer; R M Zinkernagel; H Hengartner
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

6.  Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.

Authors:  M Martin; H Schneider; A Azouz; C E Rudd
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

7.  Altered proliferative response by T lymphocytes of Ly-6A (Sca-1) null mice.

Authors:  W L Stanford; S Haque; R Alexander; X Liu; A M Latour; H R Snodgrass; B H Koller; P M Flood
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

8.  Decay-accelerating factor modulates induction of T cell immunity.

Authors:  Peter S Heeger; Peter N Lalli; Feng Lin; Anna Valujskikh; Jinbo Liu; Nasima Muqim; Yuanyuan Xu; M Edward Medof
Journal:  J Exp Med       Date:  2005-05-09       Impact factor: 14.307

9.  Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells.

Authors:  Sayuri Yamazaki; Tomonori Iyoda; Kristin Tarbell; Kara Olson; Klara Velinzon; Kayo Inaba; Ralph M Steinman
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

10.  Quantitative differences in lipid raft components between murine CD4+ and CD8+ T cells.

Authors:  Valeria de Mello Coelho; Dzung Nguyen; Banabihari Giri; Allyson Bunbury; Eric Schaffer; Dennis D Taub
Journal:  BMC Immunol       Date:  2004-01-30       Impact factor: 3.615

View more
  21 in total

1.  Depletion of complement does not impact initiation of xenobiotic-induced autoimmune disease.

Authors:  David M Cauvi; Christopher B Toomey; K Michael Pollard
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

2.  Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis.

Authors:  Qing Li; Danping Huang; Kristine Nacion; Hong Bu; Feng Lin
Journal:  Mol Immunol       Date:  2009-08-05       Impact factor: 4.407

Review 3.  Role and mechanism of action of complement in regulating T cell immunity.

Authors:  Jason R Dunkelberger; Wen-Chao Song
Journal:  Mol Immunol       Date:  2010-06-18       Impact factor: 4.407

4.  CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.

Authors:  Guipeng An; Takashi Miwa; Wen-Liang Song; John A Lawson; Daniel J Rader; Yun Zhang; Wen-Chao Song
Journal:  Mol Immunol       Date:  2009-03-17       Impact factor: 4.407

5.  Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection.

Authors:  Juan Carlos Varela; Carl Atkinson; Robert Woolson; Thomas E Keane; Stephen Tomlinson
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

6.  CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?

Authors:  Baalasubramanian Sivasankar; M Paula Longhi; Kathleen M E Gallagher; Gareth J Betts; B Paul Morgan; Andrew J Godkin; Awen M Gallimore
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

7.  Modulation of protective T cell immunity by complement inhibitor expression on tumor cells.

Authors:  Juan C Varela; Masaki Imai; Carl Atkinson; Rieko Ohta; Michelle Rapisardo; Stephen Tomlinson
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

8.  Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice.

Authors:  Takashi Miwa; Lin Zhou; Michael A Maldonado; Michael P Madaio; Robert A Eisenberg; Wen-Chao Song
Journal:  J Immunol       Date:  2012-10-29       Impact factor: 5.422

9.  Complement factor C7 contributes to lung immunopathology caused by Mycobacterium tuberculosis.

Authors:  Kerry J Welsh; Cole T Lewis; Sydney Boyd; Michael C Braun; Jeffrey K Actor
Journal:  Clin Dev Immunol       Date:  2012-07-30

10.  Vaccinia virus-specific molecular signature in atopic dermatitis skin.

Authors:  Dmitry N Grigoryev; Michael D Howell; Tonya N Watkins; Yu-Chi Chen; Chris Cheadle; Mark Boguniewicz; Kathleen C Barnes; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.